Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $56.6 million.

  • CorMedix's Cash & Current Investments rose 2292.93% to $56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.6 million, marking a year-over-year increase of 2292.93%. This contributed to the annual value of $51.7 million for FY2024, which is N/A changed from last year.
  • Per CorMedix's latest filing, its Cash & Current Investments stood at $56.6 million for Q3 2025, which was up 2292.93% from $190.7 million recorded in Q2 2025.
  • CorMedix's 5-year Cash & Current Investments high stood at $190.7 million for Q2 2025, and its period low was $45.6 million during Q2 2024.
  • Moreover, its 5-year median value for Cash & Current Investments was $60.3 million (2022), whereas its average is $70.1 million.
  • In the last 5 years, CorMedix's Cash & Current Investments crashed by 4684.0% in 2024 and then soared by 31813.33% in 2025.
  • Over the past 5 years, CorMedix's Cash & Current Investments (Quarter) stood at $65.5 million in 2021, then decreased by 10.19% to $58.8 million in 2022, then soared by 47.28% to $86.6 million in 2023, then crashed by 40.31% to $51.7 million in 2024, then rose by 9.47% to $56.6 million in 2025.
  • Its Cash & Current Investments stands at $56.6 million for Q3 2025, versus $190.7 million for Q2 2025 and $77.5 million for Q1 2025.